A Prospective Phase 2 Trial of Reirradiation With Stereotactic Body Radiation Therapy Plus Cetuximab in Patients With Previously Irradiated Recurrent Squamous Cell Carcinoma of the Head and NeckJohn A. Vargo, Dwight E. Heron, Robert L. Ferris et al.|International Journal of Radiation Oncology*Biology*Physics|2015Cited by 156
Occult Primary Head and Neck Squamous Cell Carcinoma: Utility of Discovering Primary LesionsKara S. Davis, Umamaheswar Duvvuri, Seungwon Kim et al.|Otolaryngology|2014Cited by 68
Transoral Robotic Surgery and the Unknown Primary: A Cost‐Effectiveness AnalysisJ. Kenneth Byrd, Umamaheswar Duvvuri, Kenneth J. Smith et al.|Otolaryngology|2014Cited by 53
TMEM16A/ANO1 suppression improves response to antibody‐mediated targeted therapy of EGFR and HER2/ERBB2Sucheta Kulkarni, Umamaheswar Duvvuri, Anke Bill et al.|Genes Chromosomes and Cancer|2017Cited by 46
Association of pretreatment body mass index and survival in human papillomavirus positive oropharyngeal squamous cell carcinomaWilliam G. Albergotti, Robert L. Ferris, Kara S. Davis et al.|Oral Oncology|2016Cited by 25